Related Experiment Videos

Aortic valve replacement with a pulmonary autograft in infants with critical aortic stenosis

G Südow1, L Solymar, H Berggren

  • 1Department of Thoracic Surgery, University of Göteborg, Sweden.

Insights

The Ross operation, a pulmonary autograft aortic valve replacement, showed promising results in infants with critical aortic stenosis. Most survivors are medication-free, highlighting its potential for complex pediatric heart conditions.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery

Background:

  • Critical aortic stenosis in infants presents a significant surgical challenge.
  • Previous palliative procedures often fail, necessitating advanced interventions.
  • The Ross operation offers a potential solution for severe aortic valve disease in neonates and infants.

Purpose of the Study:

  • To evaluate the outcomes of the Ross operation in infants with critical aortic stenosis.
  • To assess the efficacy and safety of pulmonary autograft use in this pediatric population.

Main Methods:

  • Seven infants (age 5 weeks to 9 months) with critical aortic stenosis underwent the Ross operation.
  • Most patients had prior failed palliative cardiac surgeries.
  • One patient received the Ross procedure as a primary intervention for a hypoplastic aortic valve ring.

Main Results:

  • Two operative deaths occurred, both associated with severe endocardial fibroelastosis.
  • One late death 1 year post-operation was due to hypertrophic cardiomyopathy and pulmonary hypertension.
  • The remaining patients are doing well, off medication, with good autograft function and only trivial regurgitation in two cases.

Conclusions:

  • The Ross operation can be a life-saving procedure for infants with critical aortic stenosis, even after failed palliations.
  • While risks exist, particularly with underlying conditions like endocardial fibroelastosis, the pulmonary autograft demonstrates durable function in survivors.
  • This study supports the Ross operation as a viable option for select pediatric patients with severe aortic valve disease.

Related Concept Videos